Pharmacologie cardiovasculaire


Accueil Programme synoptique Programme détaillé Posters Abstracts Anciens congrès Contact
Pharmacologie cardiovasculaire mardi 15 juin 2021 Sessions parallèles de communications orales Sessions parallèles de communications orales • S26 • 11h10 > 12h10 • Pharmacologie cardiovasculaire • Salle 3 Sessions parallèles de communications orales Modérateurs : Youssef Bennis, Jérémy Bellien • CO-025 • CO-025 - Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis. A 12 month multicenter study. > E. Eric TOUSSIROT • CO-026 • CO-026 - Analysis of the cardiovascular complications related to use of cannabis reported to the French Addictovigilance Network in 2011-2017 > E. Emilie JOUANJUS • CO-027 • CO-027 - Description of the novel mechanism of endothelial cytoprotection induced by ticagrelor against hypoxic lesions > C. Catherine Feliu • CO-028 • CO-028 - Temperature-sensitive transient receptor potential (TRP) channels expression and microvascular reactivity to cooling in Raynaud’s phenomenon > A. Alicia Guigui • CO-029 • CO-029 - The phosphatase activity of soluble epoxide hydrolase contributes to the pathophysiology of pulmonary hypertension associated with heart failure > T. Thomas Duflot • CO-030 • CO-030 - Short and Long-term Empagliflozin Treatment Improves Cardiac Function in Rats with Chronic Heart Failure. > Y. Yohan Stephan